Hamilton Lane Acquires Significant Equity Interest in Cosette Pharmaceuticals; Partners with Avista Capital

Capital Constellation Acquires Minority Stake in Avista Capital Partners

January 12, 2021

Financial Services

Capital Constellation, a group of institutional investors managed by Wafra Inc., acquired a minority ownership interest in New York-based private equity firm Avista Capital Partners. The strategic investment provides Avista with growth capital to expand its healthcare-focused investment platform and increase commitments to its funds; Houlihan Lokey and Kirkland & Ellis served as advisors on the transaction.

Cosette Pharmaceuticals Acquires Vyleesi from Palatin Technologies

January 3, 2024

Pharmaceuticals

Cosette Pharmaceuticals, a U.S. specialty pharmaceutical company backed by Avista Healthcare Partners, has acquired the Vyleesi (bremelanotide) product and related intellectual property from Palatin Technologies. The deal transfers five Orange Book-listed patents (protection through 2041) and aims to expand Cosette’s women's health portfolio while ensuring continued patient access during the transition.

Avista Capital Partners and VHC Investco Acquire Vision Healthcare NV

June 1, 2020

Consumer Products

Avista Capital Partners, together with VHC Investco and company management, acquired Belgium-based Vision Healthcare NV in a transaction valuing the company at €305 million (approximately $336 million). Avista and VHC Investco/management will each hold a 50% ownership interest; the partnership will support Vision's omni-channel, direct-to-consumer growth and geographic expansion across Europe and beyond.

Avista Capital Partners Acquires Taconic Biosciences

November 1, 2022

Biotechnology

Avista Capital Partners has acquired Taconic Biosciences from H.I.G. Capital. Taconic, a Rensselaer, New York–based provider of genetically engineered murine research models and related preclinical services, will leverage Avista's healthcare investing expertise to pursue organic growth and strategic acquisitions in the GEMs market.

Avista Capital Partners Invests in eMolecules

March 25, 2021

Healthcare Services

Avista Capital Partners has signed a definitive agreement to invest in eMolecules, a San Diego–based e-procurement and marketplace platform for high-value chemicals and bioreagents used in drug discovery. Financial terms were not disclosed; Avista said the investment will support eMolecules' growth and expansion into additional biopharma and academic customers.

Avista Capital Partners Acquires WellSpring Consumer Healthcare

August 23, 2022

Consumer Products

Avista Capital Partners completed the acquisition of WellSpring Consumer Healthcare from Audax Private Equity. WellSpring, founded in 1999 and headquartered in Sarasota, Florida, is a developer and marketer of over-the-counter and personal care brands (including Bactine, Bonine, Emetrol and Glaxal Base); Avista plans to support growth through product innovation, distribution expansion and strategic acquisitions.